Glucocorticoids in laryngology: a review

Abstract

Objectives/hypothesis: To provide the otolaryngologist an evidence-based sound review of glucocorticoid use for laryngeal pathology.

Study design: Review of contemporary peer-reviewed literature as well as review articles.

Methods: A review of the literature regarding glucocorticoids as a therapeutic intervention for the treatment of benign laryngeal pathology and laryngeal manifestations of systemic disease was performed. Review included both systemic administration as well as local injection.

Results: Glucocorticoids, administered in the critical care setting for planned extubation, markedly reducing the risk of reintubation and remain a rudimentary pharmacologic adjunct in laryngeal manifestations of common autoimmune and inflammatory disorders. Intralesional injection has reduced the rate of surgical intervention for benign inflammatory primary laryngeal pathology.

Conclusions: Glucocorticoids are effective in the treatment of a number of laryngeal pathologies, through both systemic and intralesional administration. However, a clear consensus for utilization of glucocorticoids in the treatment of specific laryngeal disorders has yet to be published.

Keywords: Steroids; glucocorticoids; vocal folds; voice.